Overview

A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Status:
Completed
Trial end date:
2019-12-09
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the PK of AMG 510 administered in the fasted and fed state in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Amgen